Clearing the Path

Clearing the Path

Smoothing the route to market for your biologics by avoiding HCP delays

Written byCytiva UK Limited andCytiva
| 1 min read

The stakes are high in biologics development, especially in host cell protein (HCP) analysis. Get it wrong and it could delay your development cycle. HCPs are complex. Scientists use a variety of biological expression systems to produce pharmaceutical drugs—systems based around bacteria, yeast, mammalian cells, and plant cells—and each system has a unique HCP profile. See how optimizing your HCP assays can smooth your route to market.

Download this white paper to learn how to optimize host cell protein assays, courtesy of Cytiva.

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - May/June 2025

The Benefits, Business Case, And Planning Strategies Behind Lab Digitalization

Joining Processes And Software For a Streamlined, Quality-First Laboratory

Lab Manager May/June 2025 Cover Image